This article was originally published in The Gray Sheet
Executive SummaryFirms agree to co-develop pre-filled, U-100 NovoLog insulin analog cartridges for use with Medtronic Paradigm external insulin pumps. The manufacturers plan clinical studies and medical education efforts for the combined technologies, which would eliminate the current need for manual transfer of insulin from a vial to the Paradigm pump reservoir every two to three days...
You may also be interested in...
The FDA has readied plans for hastened emergency-use approvals of coronavirus test kits after an infected US citizen returned to Washington State from Wuhan province in China. See what the FDA’s Megan McSeveney said about it here.
Despite obvious similarities in the contentious reviews of Sarepta’s Vyondys 53 and its predecessor Exondys 51, drug developers should focus on the differences between the two reviews.
Scrip traces some of the prominent changes in the corner office at front-line, family-owned Indian firms Cipla and Dr Reddy’s in the decade gone by.